ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Refixia 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung - 
66216001 Novo Nordisk Pharma AG
Refixia 500 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung05.09.2017
  05.09.2017
Coagulation Factor Ix (B02BD04) 
WHO-DDD 
06.01.10. 
06.01.10. 
B  
Yes 
IPCI
889.38Yes
    
10 %953.55
  
7680662160019Biotechnologika
7229875 
Composition
Praeparatio cryodesiccata: nonacogum beta pegolum 500 U.I., natrii chloridum, histidinum, saccharum 10 mg, mannitolum, polysorbatum 80, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, pro vitro corresp. natrium 0.972 mg/ml. Solvens: histidinum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium.
Packungsbestandteile
Solvens
 
Lyophilisate and solvent 
  
  
BAG: Active AgentDose
Nonacogum beta Pegolum500 UI
 
Inactive agents
Histidine
 
Praeparatio cryodesiccata:
 
Lyophilisate and solvent 
  
 
Active AgentDose
Nonacogum beta Pegolum500 UI
BAG: Active AgentDose
Nonacogum beta Pegolum500 UI
 
Inactive agentsDose
Acidum Hydrochloridum ad Ph 
Histidine 
Mannitol 
Sodium Chloride 
Natrii Hydroxidum ad Ph 
Polysorbatum 80 
Saccharum10 mg
 
Solvens
 
Lyophilisate and solvent 
  
  
BAG: Active AgentDose
Nonacogum beta Pegolum500 UI
 
Inactive agents
Acidum Hydrochloridum ad Ph
Histidine
Natrii Hydroxidum ad Ph
 
Source
Data was imported : 04.07.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home